FDA staff raises eye damage concerns for GSK's blood cancer drug-February 2024-www.financetom.com

FDA staff raises eye damage concerns for GSK's blood cancer drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

FDA staff raises eye damage concerns for GSK's blood cancer drug

Jul 15, 2025 5:50 AM

July 15 (Reuters) - The U.S. Food and Drug

Administration's staff reviewers on Tuesday raised safety

concerns that GSK's blood cancer drug, when used in

combination with other treatments, may cause eye damage in

patients.

Previous page： World Steel Association elects JSW Steel's Sajjan Jindal as Chairman; becomes first Indian to hold the post Next page： Why India isn’t revising digital tax regime despite agreeing to global tax reforms

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

World Steel Association elects JSW Steel's Sajjan Jindal as Chairman; becomes first Indian to hold the post

Oct 13, 2021

The World Steel Association (WSA) on Wednesday said that it has elected JSW Steel Chairman and Managing Director Sajjan Jindal as its Chairman for the 2021-22 period. With this, Jindal becomes the first representative from India to serve as Chairman of the WSA.

Why India isn’t revising digital tax regime despite agreeing to global tax reforms

Oct 14, 2021

A total of 136 countries, including India, agreed to the new tax reforms, which will ensure that all multinational enterprises pay a fair share of tax wherever they operate. The countries agreed to subject these MNEs to a minimum 15% tax from 2023.

Facebook says interim ads chief will fill role permanently

Oct 14, 2021

Facebook Inc on Wednesday said it appointed Nicola Mendelsohn as its new head of global business group to oversee the social media company's vast advertising business.

Billionaire Alibaba founder Jack Ma reappears in Hong Kong

Oct 12, 2021

The Chinese billionaire has been keeping a low profile since delivering a speech in October last year in Shanghai criticising China's financial regulators. That triggered a chain of events that resulted in the shelving of his Ant Group's mega IPO.